European Archives - Page 285 of 1449 - European Medical Journal

Chronic Inflammation Linked to Increased Affective Disorders

Chronic exposure to systemic inflammation may be associated to a greater risk of affective disorders.

Can Post-Treatment MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy?

Pathologic complete response was accurately predicted by post-treatment MRI in patients with early triple-negative breast cancer having undergone neoadjuvant chemoimmunotherapy.

Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Pharma seized the spotlight at Cannes Lions – here's why

In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.

Hyperbaric Oxygen Therapy Leads Diabetic Foot Ulcer Treatment Rankings in New Meta-Analysis

Hyperbaric oxygen therapy ranks highest for healing diabetic foot ulcers but may raise amputation risk, new network meta-analysis reveals.

Study Links Bifidobacterium Deficit in Infants in the USA to Gut Dysbiosis

One in four U.S. infants lacks Bifidobacterium, a key gut microbe essential for immune and metabolic health.

Head-to-Head Trial Supports Cheaper Hepatitis C Drug

Beyond the head-to-head comparison, the study also explored innovative strategies to simplify or shorten treatment.

Illustration of scientific tools

New report calls for faster R&D for rare diseases

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

GSK’s Matt Mortimer-Ryan on behaviour-led pharma marketing

Matt Mortimer Ryan, GSK, discusses how understanding patients’ emotional drivers can unlock more impactful pharma marketing campaigns.

Unusual Yeast Fungaemia Patterns Seen in Injection Drug Users

French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.